Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |